Patent opinions from the Eastern District of Texas and the U.S. Court of Appeals for the Federal Circuit

Weekly Digest
Fed. Cir.

Medivis, Inc. v. Novarad Corp., No. 24-1951 (Fed. Cir. Dec. 10, 2025)

Affirmed
Court
U.S. Court of Appeals for the Federal Circuit
Case No.
No. 24-1951
Decided
December 10, 2025
Judge
Per curiam (Rule 36)
Document
Rule 36 Judgment
Length
2 pages

NOTE: This disposition is nonprecedential. United States Court of Appeals

for the Federal Circuit

MEDIVIS, INC.,

Appellant

v.

NOVARAD CORP.,

Appellee

2024-1951

Appeal from the United States Patent and Trademark Office, Patent Trial and Appeal Board in No. IPR2023-00045.

JUDGMENT

ADAM STEINMETZ, Desmarais LLP, Washington, DC, argued for appellant. Also represented by BETTY H. CHEN, San Francisco, CA; TAEG SANG CHO, JOHN M. DESMARAIS, New York, NY. JOSEPH HARMER, Thorpe North & Western, LLP, Salt Lake City, UT, argued for appellee. Also represented by JED H. HANSEN.

2THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

cuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

Figure on page 2 of the opinion

December 10, 2025

Date

Text extracted from the official PDF and reflowed for reading. It is not a certified transcript — the PDF linked above is the authoritative document.

Analysis is coming soon.

A plain-English account of the issues, facts and holding, written by Patent Case Watch. The opinion itself — its full text, its PDF and everything else on this page — stays free to read for everyone, always.

Cite this opinion

Medivis, Inc. v. Novarad Corp., No. 24-1951 (Fed. Cir. Dec. 10, 2025).

Record ID
CAFC-24-1951-20251210
Permalink
https://patentcasewatch.com/opinions/CAFC-24-1951-20251210

No reporter citation is shown because the official source does not supply one; none is inferred here. Check the opinion and a citator before relying on this form.